Search

Date 2016 Author/Creator SenGupta, Devi

1. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Issue 12 (December 2016)

Authors:
Gaur, Aditya H; Kizito, Hilda; Prasitsueubsai, Wasana; Rakhmanina, Natella; Rassool, Mohammed; Chakraborty, Rana; Batra, Jagmohan; Kosalaraksa, Pope; Luesomboon, Wicharn; Porter, Danielle; Shao, Yongwu; Myers, Michael; Ting, Lillian; SenGupta, Devi; Quirk, Erin; Rhee, Martin S
Journal:
Lancet
Issue:
Volume 3:Issue 12(2016)
Page Start:
e561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. (15th April 2016)

Authors:
Pozniak, Anton; Arribas, Jose R.; Gathe, Joseph; Gupta, Samir K.; Post, Frank A.; Bloch, Mark; Avihingsanon, Anchalee; Crofoot, Gordon; Benson, Paul; Lichtenstein, Kenneth; Ramgopal, Moti; Chetchotisakd, Ploenchan; Custodio, Joseph M.; Abram, Michael E.; Wei, Xuelian; Cheng, Andrew; McCallister, ...
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 71:Number 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search